Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine. (Q38372521)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

title

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Ana Guevara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Robinson Cabello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Linn Woelber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Elmar Joura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Olaf Reich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Christine Shields

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Misoo C Ellison

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Amita Joshi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Alain Luxembourg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

English

0 references

publication date

5 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

5050-5057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

Global burden of human papillomavirus and related diseases.

27 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Human papillomavirus vaccines--immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

On differences between immunity and immunological memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.07.017

10.1016/J.VACCINE.2017.07.017

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28789851%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference